BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17762444)

  • 21. Phase II study of epirubicin in combination with weekly docetaxel for patients with advanced NSCLC who have failed or relapsed after the frontline platinum-based chemotherapy.
    Lin CM; Chen CH; Chang JW; Tsao TC
    Am J Clin Oncol; 2009 Apr; 32(2):169-73. PubMed ID: 19307958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of menogaril in patients with squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; Barrett RJ; Gallup DG
    Gynecol Oncol; 1994 Feb; 52(2):229-31. PubMed ID: 8314144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Fracasso PM; Blessing JA; Wolf J; Rocereto TF; Berek JS; Waggoner S
    Gynecol Oncol; 2003 Jul; 90(1):177-80. PubMed ID: 12821360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II study of carboplatin and cisplatin in advanced or recurrent squamous carcinoma of the uterine cervix.
    Morris M; Gershenson DM; Burke TW; Mitchell MF; Levenback C; Atkinson N; Wharton JT
    Gynecol Oncol; 1994 May; 53(2):234-8. PubMed ID: 8188085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study.
    Nezhat F; Wadler S; Muggia F; Mandeli J; Goldberg G; Rahaman J; Runowicz C; Murgo AJ; Gardner GJ
    Gynecol Oncol; 2004 Apr; 93(1):144-8. PubMed ID: 15047228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy of advanced squamous carcinoma of the cervix: a phase I-II study of high-dose cisplatin and cyclophosphamide. A pilot study of the Gynecologic Oncology Group.
    Jobson VW; Muss HB; Thigpen JT; Homesley HD; Bundy B
    Am J Clin Oncol; 1984 Aug; 7(4):341-5. PubMed ID: 6540048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of docetaxel and cisplatin chemotherapy in 5-fluorouracil/cisplatin pretreated esophageal cancer.
    Shim HJ; Cho SH; Hwang JE; Bae WK; Song SY; Cho SB; Lee WS; Joo YE; Na KJ; Chung IJ
    Am J Clin Oncol; 2010 Dec; 33(6):624-8. PubMed ID: 20142726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck.
    Cho BC; Keum KC; Shin SJ; Choi HJ; Lee YJ; Kim SH; Choi EC; Kim JH
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):27-32. PubMed ID: 19381630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Docetaxel/cisplatin as first-line chemotherapy in patients with head and neck carcinoma: a phase II trial.
    Baur M; Kienzer HR; Schweiger J; DeSantis M; Gerber E; Pont J; Hudec M; Schratter-Sehn AU; Wicke W; Dittrich C
    Cancer; 2002 Jun; 94(11):2953-8. PubMed ID: 12115384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Muggia FM; Blessing JA; Waggoner S; Berek JS; Monk BJ; Sorosky J; Pearl ML
    Gynecol Oncol; 2005 Jan; 96(1):108-11. PubMed ID: 15589588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: a Gynecologic Oncology Group study.
    Fiorica JV; Blessing JA; Puneky LV; Secord AA; Hoffman JS; Yamada SD; Buekers TE; Bell J; Schilder JM;
    Gynecol Oncol; 2009 Nov; 115(2):285-9. PubMed ID: 19726073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
    Muggia FM; Blessing JA; McGehee R; Monk BJ
    Gynecol Oncol; 2004 Aug; 94(2):483-7. PubMed ID: 15297192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
    Santin AD; Sill MW; McMeekin DS; Leitao MM; Brown J; Sutton GP; Van Le L; Griffin P; Boardman CH
    Gynecol Oncol; 2011 Sep; 122(3):495-500. PubMed ID: 21684583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study.
    Look KY; Blessing JA; Levenback C; Kohler M; Chafe W; Roman LD
    Gynecol Oncol; 1998 Sep; 70(3):334-8. PubMed ID: 9790784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervix.
    Kudelka AP; Verschraegen CF; Levy T; Edwards CL; Fishman A; Freedman RS; Kaplan A; Kieback DG; Mante R; Ende K; Steger M; Kavanagh JJ
    Anticancer Drugs; 1996 Jun; 7(4):398-401. PubMed ID: 8826607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase II trial of tricyclic nucleoside phosphate in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
    Feun LG; Blessing JA; Barrett RJ; Hanjani P
    Am J Clin Oncol; 1993 Dec; 16(6):506-8. PubMed ID: 8256767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Monk BJ; Sill MW; Burger RA; Gray HJ; Buekers TE; Roman LD
    J Clin Oncol; 2009 Mar; 27(7):1069-74. PubMed ID: 19139430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of vinblastine in previously treated squamous carcinoma of the cervix. A Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; Barnes W; Ball H
    Am J Clin Oncol; 1990 Dec; 13(6):470-1. PubMed ID: 2239800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II trial of didemnin B (NSC #335319) in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
    Malfetano JH; Blessing JA; Homesley HD; Look KY; McGehee R
    Am J Clin Oncol; 1996 Apr; 19(2):184-6. PubMed ID: 8610646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase II trial of didemnin B (NSC No. 325319) in advanced and recurrent cervical carcinoma: a Gynecologic Oncology Group study.
    Jacobs AJ; Blessing JA; Munoz A
    Gynecol Oncol; 1992 Mar; 44(3):268-70. PubMed ID: 1541440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.